NO922936L - Fremstilling av fettsyremedikamenter - Google Patents

Fremstilling av fettsyremedikamenter

Info

Publication number
NO922936L
NO922936L NO92922936A NO922936A NO922936L NO 922936 L NO922936 L NO 922936L NO 92922936 A NO92922936 A NO 92922936A NO 922936 A NO922936 A NO 922936A NO 922936 L NO922936 L NO 922936L
Authority
NO
Norway
Prior art keywords
preparation
acid medicines
aids
fatic acid
fatic
Prior art date
Application number
NO92922936A
Other languages
English (en)
Norwegian (no)
Other versions
NO922936D0 (no
Inventor
David Frederick Horrobin
Michael David Winther
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10698951&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO922936(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of NO922936D0 publication Critical patent/NO922936D0/no
Publication of NO922936L publication Critical patent/NO922936L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Amplifiers (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO92922936A 1991-07-24 1992-07-23 Fremstilling av fettsyremedikamenter NO922936L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919116054A GB9116054D0 (en) 1991-07-24 1991-07-24 Preparation of fatty acid medicaments

Publications (2)

Publication Number Publication Date
NO922936D0 NO922936D0 (no) 1992-07-23
NO922936L true NO922936L (no) 1993-01-25

Family

ID=10698951

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922936A NO922936L (no) 1991-07-24 1992-07-23 Fremstilling av fettsyremedikamenter

Country Status (12)

Country Link
EP (1) EP0524796B1 (de)
JP (1) JPH05194244A (de)
KR (1) KR930001902A (de)
AT (1) ATE120954T1 (de)
AU (1) AU1968992A (de)
CA (1) CA2073913A1 (de)
DE (1) DE69202019D1 (de)
FI (1) FI923357A7 (de)
GB (1) GB9116054D0 (de)
IE (1) IE922250A1 (de)
NO (1) NO922936L (de)
ZA (1) ZA925562B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214062A (en) * 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
US5674901A (en) * 1995-06-01 1997-10-07 Wisconsin Alumni Research Foundation Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
GB9211229D0 (en) * 1992-05-27 1992-07-08 Efamol Holdings Fatty acid treatment
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
WO1995009622A1 (en) * 1993-10-06 1995-04-13 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
US5856149A (en) * 1995-06-01 1999-01-05 Wisconsin Alumni Research Foundation Method of producing conjugated fatty acids
DE19611953A1 (de) * 1996-03-26 1997-10-02 Beiersdorf Ag Verwendung von ungesättigten Monocarbonsäuren gegen Superinfektionen
US7381413B1 (en) 1998-04-17 2008-06-03 University Of Vermont And State Agricultural College Methods and products related to metabolic interactions in disease
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
ES2209658B1 (es) * 2002-12-05 2005-10-01 Proyecto Empresarial Brudy, S.L. Utilizacion del acido docosahexaenoico como principio activo para el tratamiento de la lipodistrofia.
KR20050118057A (ko) * 2004-04-24 2005-12-15 김상희 아세틸디아실글리세롤류의 화합물을 유효성분으로함유하는 항암제 및 건강식품
EP1597978A1 (de) 2004-05-17 2005-11-23 Nutricia N.V. Synergie von GOS und polyfruktose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
SI1758469T2 (sl) * 2004-06-22 2013-12-31 N.V.Nutricia Izboljšanje integritete bariere pri HIV pacientih z uporabo maščobnih kislin
JP2006282644A (ja) * 2005-04-05 2006-10-19 Idemitsu Kosan Co Ltd 疲労回復剤
EP2826481A1 (de) 2006-03-15 2015-01-21 Suntory Holdings Limited Zusammensetzungen, die Riboflavin und Sesaminklassenverbindungen enthält
US8557764B2 (en) 2007-01-26 2013-10-15 The Regents Of The University Of Colorado, A Body Corporate Methods of modulating immune function
EP3342409A1 (de) 2007-03-15 2018-07-04 Suntory Holdings Limited Mittel gegen müdigkeit
MX2010000424A (es) 2007-07-09 2010-08-10 Easter Virginia Medical School Derivados de nucleosidos sustituidos con propiedades antivirales y antimicrobianas.
CN101801370B (zh) * 2007-09-19 2013-06-12 三得利控股株式会社 含有芝麻素类和花生四烯酸类的组合物
JP2009073747A (ja) * 2007-09-19 2009-04-09 Suntory Ltd アラキドン酸を有効成分とする抗疲労剤
WO2020077420A1 (en) * 2018-10-16 2020-04-23 MOREIRA, Nivaldo José Extract of jatropha curcas seed oil

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4017979A1 (de) * 1990-06-05 1991-12-12 Meyer Lucas Gmbh & Co Lipid- bzw. phospholipid-zusammensetzungen sowie diese enthaltendes mittel zur behandlung von erkrankungen sowie auf die zellmembrane zurueckzufuehrende stoerungen

Also Published As

Publication number Publication date
DE69202019D1 (de) 1995-05-18
CA2073913A1 (en) 1993-01-25
IE922250A1 (en) 1993-01-27
AU1968992A (en) 1993-01-28
ZA925562B (en) 1993-04-28
FI923357L (fi) 1993-01-25
FI923357A0 (fi) 1992-07-23
FI923357A7 (fi) 1993-01-25
EP0524796B1 (de) 1995-04-12
GB9116054D0 (en) 1991-09-11
ATE120954T1 (de) 1995-04-15
NO922936D0 (no) 1992-07-23
JPH05194244A (ja) 1993-08-03
KR930001902A (ko) 1993-02-22
EP0524796A1 (de) 1993-01-27

Similar Documents

Publication Publication Date Title
NO922936D0 (no) Fremstilling av fettsyremedikamenter
MX9201621A (es) Aminas heterociclicas utiles en la terapia de asma e inflamacion del tracto respiratorio.
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
HU9603042D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
NO950784L (no) Fettsyrederivater
NO893240D0 (no) Anvendelse av alfa-aminoborsyrederivater til profylaktisk og behandling av virussykdommer.
ES2054715T3 (es) Nuevos derivados de naftaleno y productos farmaceuticos antialergicos y antiinflamatorios.
IT1256697B (it) Medicamenti per trattare condizioni infiammatorie o per analgesia.
ATE74271T1 (de) Ketonderivate als arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
NO933000D0 (no) Anvendelse av c1-inaktivator for fremstilling av et legemiddel for profylakse og behandling av bestemte sykdommer
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
CA2120062A1 (en) Use of Sulodexide and of Medicines Containing It in the Treatment of Diabetic Nephropathy
DK0476113T3 (da) Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose
AU1956092A (en) Pharmaceutical agent for treatment of withdrawal symptoms
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
NO962259L (no) Anvendelse av dimeticon for behandling av aphthae og stomatitt
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
FR2663230B1 (fr) Dispositif d'hygiene et de traitement.
DE59200566D1 (de) Aryl-Chinolyl-substituierte 1,4-Dihydropyridin-dicarbonsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln.
NO960347D0 (no) Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
SE9403861D0 (sv) Novel medicinal use
BG94567A (en) Medicaments for the treatment of aids and method for its application
IT8520736A0 (it) Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari.
IT8646805A0 (it) Sussidio per la prevenzione e la cura delle piaghe da decubito